
|Articles|May 1, 1997
Supplements and Featured Publications
- Inflammatory Bowel Disease: A Managed Care Perspective
- Volume 3
- Issue 6 Suppl
Goals and Objectives
Advertisement
Articles in this issue
over 28 years ago
Introductionover 28 years ago
Inflammatory Bowel Disease: Ulcerative Colitisover 28 years ago
Inflammatory Bowel Disease: Crohn's Diseaseover 28 years ago
Selected Abstractsover 28 years ago
CME Quizover 28 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
3
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
4
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
5













































